Delhi High Court Seeks Fortis’  Reply To Daiichi’s Plea Against Manipal Deal
A person holds a tester spray bottle of a medicine.  (Photographer: Mark Elias/Bloomberg)

Delhi High Court Seeks Fortis’ Reply To Daiichi’s Plea Against Manipal Deal

Bookmark
The Delhi High Court today asked Fortis Healthcare Ltd., which is going through the process of restructuring, to give its response on Japanese pharma major Daiichi Sankyo’s plea to maintain status ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.